Search research articles
Contact Us
Filters
Showing results (201-210 of 304) with videos related to
Page
of 31
Sort By:
JAMA Neurology
|
August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
Ju-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Mediators of Inflammation
|
August 6, 2025
Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27<sup>+</sup>IgD<sup>+</sup> Unswitched Memory B Cell Profiles
Bérénice Hansen, Raul Da Costa, Dominique Revets, et al.
NPJ Parkinson'S Disease
|
September 8, 2021
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
Luca Baldelli, Sebastian Schade, Silvia Jesús, et al.
Nature Communications
|
May 9, 2026
High-resolution multi-omics enhances prediction and detection of smORF-encoded proteins in the human gut microbiome
Megan E Davin, Júlia Ortís Sunyer, Luis F Delgado, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study
Elke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Nature Medicine
|
May 19, 2026
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
Ivan Martinez-Valbuena, Maziar Emamikhah, Diana A Olszewska, et al.
Frontiers in Neurology
|
September 9, 2015
A Practical Guide to Immunoassay Method Validation
Ulf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Frontiers in Aging Neuroscience
|
July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned
Sebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Neurology
|
June 3, 2024
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies
Katharina Bolsewig, Annemartijn A J M van Unnik, Elena R Blujdea, et al.
Brain : a Journal of Neurology
|
December 11, 2021
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Ilaria Poggiolini, Vandana Gupta, Michael Lawton, et al.
Page
of 31
Search research articles
Search
Showing results (201-210 of 304) with videos related to
Sort By:
Page
of 31
JAMA Neurology
|
August 28, 2013
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
Ju-Hee Kang, David J Irwin, Alice S Chen-Plotkin, et al.
Mediators of Inflammation
|
August 6, 2025
Immunophenotyping of Patients With Rheumatoid Arthritis Reveals Difference in CD27<sup>+</sup>IgD<sup>+</sup> Unswitched Memory B Cell Profiles
Bérénice Hansen, Raul Da Costa, Dominique Revets, et al.
NPJ Parkinson'S Disease
|
September 8, 2021
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients
Luca Baldelli, Sebastian Schade, Silvia Jesús, et al.
Nature Communications
|
May 9, 2026
High-resolution multi-omics enhances prediction and detection of smORF-encoded proteins in the human gut microbiome
Megan E Davin, Júlia Ortís Sunyer, Luis F Delgado, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 13, 2016
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study
Elke Kalbe, Sarah Petra Rehberg, Ines Heber, et al.
Nature Medicine
|
May 19, 2026
A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism
Ivan Martinez-Valbuena, Maziar Emamikhah, Diana A Olszewska, et al.
Frontiers in Neurology
|
September 9, 2015
A Practical Guide to Immunoassay Method Validation
Ulf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Frontiers in Aging Neuroscience
|
July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned
Sebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Neurology
|
June 3, 2024
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies
Katharina Bolsewig, Annemartijn A J M van Unnik, Elena R Blujdea, et al.
Brain : a Journal of Neurology
|
December 11, 2021
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
Ilaria Poggiolini, Vandana Gupta, Michael Lawton, et al.
Page
of 31